Following a new all-time high (ATH) of $126,199 on Binance, Bitcoin (BTC) is now consolidating in the low $120,000 range. Latest exchange data – such as Cumulative Volume Delta (CVD) Confirmation Score – suggests that BTC is benefitting from strong underlying demand.
CVD Confirmation Shows Strong Demand For Bitcoin
According to a CryptoQuant Quicktake post by contributor Arab Chain, Bitcoin’s CVD Confirmation Score – a 30-day rolling correlation between Bitcoin’s price and the CVD – is suggesting a strong resynchronization of the trend.
For the uninitiated, the CVD Confirmation Score measures the 30-day correlation between Bitcoin’s price and the CVD, which tracks the net difference between taker buy and sell volumes on exchanges. A high score (above 0.7) indicates that price increases are backed by real buying pressure, while a low or negative score suggests weak or speculative momentum.
Latest data from Binance shows that the CVD Confirmation Score currently hovers around 0.8 to 0.9, indicating that the current price surge is largely driven by genuine taker buying rather than a technical bounce or a short squeeze.
Source: CryptoQuant
Past data also suggests that whenever this data point has remained about 0.7 for an extended period, price corrections tend to be relatively shallow and short-lived. This is because new liquidity in the market quickly absorbs any incoming supply of BTC.
The CryptoQuant analyst remarked that if the CVD Confirmation Score continues to hover above 0.7 – coupled with a decisive breakout above the $124,000 – $126,000 resistance zone – then it could be on its way to a potential target of as high as $135,000.
However, any negative divergence with BTC price rising and CVD Confirmation Score dropping below 0.4 should be seen as a warning sign, as it increases the likelihood of distribution or liquidation pressure.
Conversely, the $112,000 – $115,000 and $108,000 – $110,000 stand out as strong support levels for BTC. At these price levels, the CVD Confirmation Score should remain steady to ensure the uptrend remains intact. Arab Chain added:
The underlying trend is bullish and supported by real inflows on Binance, the highest-volume exchange globally. Monitor three confirmation signals: CVD Confirmation stays high, open interest remains moderate, and funding does not become excessive. Any clear imbalance across these metrics will be the first warning of a momentum shift.
Is BTC Due For A Correction?
While bulls are hoping for an extended rally for BTC, some analysts aren’t quite convinced about the digital asset surging to new highs in the near term. For instance, crypto analyst ZVN recently stated that BTC may witness a pullback before its next surge to $150,000.
Similarly, fellow crypto analyst Dick Dandy recently predicted that BTC may witness a massive 60% price correction, falling all the way down to $43,900. At press time, BTC trades at $118,791, down 1.8% in the past 24 hours.
Bitcoin trades at $118,791 on the daily chart | Source: BTCUSDT on TradingView.com
Featured image from Unsplash, charts from CryptoQuant and TradingView.com
2025-10-11 06:086mo ago
2025-10-11 01:006mo ago
Bitcoin Miner Health Index Hits 59%: A Bullish Signal For The Market?
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure
Bitcoin is currently consolidating below the $125,000 level after a sharp correction that pushed the price down to $120,000, a key psychological and technical area of support. Despite the recent volatility, bulls are showing resilience, holding price levels that suggest the broader uptrend remains intact. However, uncertainty persists as some analysts warn that a deeper correction toward lower demand zones could still occur before the next leg higher.
Interestingly, onchain data provides a more optimistic signal. Metrics indicate that Bitcoin miners are not in a hurry to sell, suggesting strong conviction in the market’s long-term trajectory. This stability from miners — historically one of the largest sources of selling pressure — reflects growing confidence in the sustainability of current price levels.
As the market navigates this phase of consolidation, traders are watching whether Bitcoin can reclaim $125K and establish a new base for continuation. For now, the combination of miner confidence and stable demand suggests the market is preparing for its next decisive move rather than signaling exhaustion.
Bitcoin Miners Remain Strong
Top onchain analyst Axel Adler shared new insights into the state of the Bitcoin mining economy through the Miner Financial Health Index — a composite metric designed to measure the financial condition of miners by accounting for hashprice, block profit, fee share, and overall cash flow. According to Adler, the index currently stands at 59%, which represents a healthy, neutral-to-bullish mining economy.
Bitcoin Miner Financial Health & Demand-Supply Balance | Source: Axel Adler
This reading indicates that miners are operating in a stable environment with balanced profitability and no signs of distress. Importantly, the absence of excessive stress or euphoria suggests that miners are not under pressure to liquidate holdings, a factor that often contributes to market stability. Historically, periods when the index stays within the 50–65% range have coincided with steady price growth, as miners tend to accumulate or hold their rewards rather than selling into rallies.
Adler notes that a sharp rise above 80% would mark the beginning of a distribution phase, typically associated with increased miner selling as profits peak. For now, the moderate reading highlights that the current cycle still has room for growth before reaching overheated levels.
This insight aligns with other onchain indicators showing robust network activity and strong miner confidence, reinforcing the notion that Bitcoin’s recent correction remains a healthy consolidation phase rather than a sign of structural weakness. As long as miners continue to operate profitably and refrain from large-scale selling, Bitcoin’s underlying market foundation remains firm — setting the stage for potential renewed momentum once price volatility subsides.
Bitcoin Price Analysis: Bulls Defend $120K Support
Bitcoin (BTC) is trading around $121,400, consolidating after a brief pullback from the $126,000 all-time high. The daily chart shows BTC holding above key support levels, with the 50-day (blue) and 100-day (green) moving averages trending upward — confirming that the broader structure remains bullish.
BTC consolidates around $121K | Source: BTCUSDT chart on TradingView
The $120,000–$121,000 zone is emerging as a short-term support area, where buyers have stepped in to defend against further downside. A sustained move above $123,500 could open the door for a retest of $125,000, while a breakdown below $120,000 would likely expose BTC to a deeper correction toward the $117,500 level, a major horizontal support that previously acted as resistance in September.
Momentum indicators suggest the market is in a cooling phase after an extended rally, allowing for potential re-accumulation before the next major move. The recent consolidation aligns with on-chain data showing miners maintaining confidence and no significant selling pressure.
Bitcoin remains structurally bullish, as long as price holds above $117,500. Traders will watch for a breakout above $125,000 to confirm renewed momentum and potentially push BTC into price discovery territory once again.
Featured image from ChatGPT, chart from TradingView.com
Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.
Sign Up for Our Newsletter!
For updates and exclusive offers enter your email.
Sebastian's journey into the world of crypto began four years ago, driven by a fascination with the potential of blockchain technology to revolutionize financial systems. His initial exploration focused on understanding the intricacies of various crypto projects, particularly those focused on building innovative financial solutions. Through countless hours of research and learning, Sebastian developed a deep understanding of the underlying technologies, market dynamics, and potential applications of cryptocurrencies.
As his knowledge grew, Sebastian felt compelled to share his insights with others. He began actively contributing to online discussions on platforms like X and LinkedIn, focusing on fintech and crypto-related content. His goal was to expose valuable trends and insights to a wider audience, fostering a deeper understanding of the rapidly evolving crypto landscape. Sebastian's contributions quickly gained recognition, and he became a trusted voice in the online crypto community.
To further enhance his expertise, Sebastian pursued a UC Berkeley Fintech: Frameworks, Applications, and Strategies certification. This rigorous program equipped him with valuable skills and knowledge regarding Financial Technology, bridging the gap between traditional finance (TradFi) and decentralized finance (DeFi). The certification deepened his understanding of the broader financial landscape and its intersection with blockchain technology.
Sebastian's passion for finance and writing is evident in his work. He enjoys delving into financial research, analyzing market trends, and exploring the latest developments in the crypto space. In his spare time, Sebastian can often be found immersed in charts, studying 10-K forms, or engaging in thought-provoking discussions about the future of finance.
Sebastian's journey as a crypto analyst and investor has been marked by a relentless pursuit of knowledge and a dedication to sharing his insights. His ability to navigate the complex world of crypto, combined with his passion for financial research and communication, makes him a valuable asset to the industry. As the crypto landscape continues to evolve, Sebastian remains at the forefront, providing valuable insights and contributing to the growth of this revolutionary technology.
2025-10-11 06:086mo ago
2025-10-11 01:046mo ago
XRP Bears Tighten Grip as $2.72 Support Faces Major Test
Ripple's XRP is showing signs of sustained weakness as bearish forces dominate both spot and derivatives markets. The token is currently trading inside a descending triangle formation, with price compressing toward the critical $2.72 support level.
2025-10-11 06:086mo ago
2025-10-11 01:166mo ago
$42M XRP Shift Sparks Speculation as Banks Eye Ripple for ISO 20022 Edge
$42 Million XRP Whale Move Sparks Speculation Amid Market UncertaintyAccording to market commentator Xaif Crypto, a massive 15 million XRP, valued at approximately $42.1 million, was transferred to the crypto exchange Bitstamp, igniting intense speculation among traders and analysts.
Source: Xaif CryptoThe sizable transaction, detected by on-chain tracking platforms, comes at a critical juncture for XRP, as the token struggles to maintain stability amid fluctuating market sentiment and renewed whale activity.
Large-scale transfers to centralized exchanges like Bitstamp are often viewed as potential sell signals, suggesting that holders might be preparing to offload substantial amounts of their assets.
This latest move, therefore, has raised eyebrows across the XRP community, with some interpreting it as a sign of impending selling pressure, while others see it as a strategic liquidity maneuver linked to institutional activity.
Market data shows XRP trading within a tight consolidation range, with the altcoin having shed off 19.8% of its value in the past week to trade at $2.44 per CoinGecko data.
Despite short-term uncertainty, on-chain metrics indicate consistent accumulation by long-term holders, suggesting that confidence in Ripple’s broader utility narrative remains intact.
Therefore, the $42.1 million XRP transfer to Bitstamp has reignited market speculation, underscoring XRP’s unmatched liquidity and testing investor sentiment.
Whether it marks strategic accumulation or large-scale distribution, one thing is certain that XRP remains a central force shaping institutional strategy and the evolving digital finance landscape.
Banks to Turn to Ripple as the Fastest Route to ISO 20022 Readiness by November 2025According to renowned crypto researcher SMQKE, global banks are increasingly positioning Ripple as their preferred path toward ISO 20022 readiness ahead of the November 2025 deadline.
The upcoming transition, mandated across the global payments ecosystem, requires financial institutions to adopt a standardized, data-rich messaging format designed to enhance transparency, interoperability, and efficiency in cross-border settlements.
ISO 20022 is more than a compliance update, it’s a structural transformation that compels banks to modernize outdated messaging and processing systems.
As legacy infrastructure struggles to adapt to the new standard’s demands, Ripple’s blockchain-based technology is emerging as the fastest, most cost-effective alternative.
By leveraging the XRP Ledger and RippleNet, institutions can streamline transactions while maintaining full regulatory alignment.
As SMQKE notes, banks are under mounting pressure to achieve ISO 20022 compliance without disrupting daily operations. Ripple’s modular technology delivers a plug-and-play upgrade path that slashes costs, accelerates integration, and ensures seamless interoperability.
With unmatched speed, low fees, and full transaction visibility, Ripple stands out as the most practical bridge between legacy systems and real-time, blockchain-powered settlement networks, just as the November 2025 deadline draws near.
ConclusionThe $42.1M XRP transfer to Bitstamp spotlights whales and institutions steering market moves. While sparking short-term sell-off speculation, it underscores XRP’s deep liquidity and strategic role in the crypto ecosystem.
On the other hand, Ripple’s push toward ISO 20022 integration positions it as more than a compliance tool, it’s a strategic accelerator for the future of global banking.
With the November 2025 deadline approaching, banks are recognizing that blockchain is no longer experimental but essential infrastructure. Ripple’s proven interoperability, cost efficiency, and regulatory alignment make it the fastest, most practical path for seamless modernization.
2025-10-11 06:086mo ago
2025-10-11 01:256mo ago
Crypto sentiment flips to ‘Fear' as Bitcoin plunges after Trump's tariffs
The last time the Crypto Fear & Greed Index dropped to this level of fear, Bitcoin’s price was trading around $80,000.
38
Crypto market sentiment has dropped to its lowest level in almost six months after US President Donald Trump announced a 100% tariff on China.
The Crypto Fear & Greed Index, which gauges overall market sentiment, fell to a “Fear” level of 27 in its Saturday’s update, representing a decline of 37 points from Friday’s “Greed” reading of 64.
The decline came as Bitcoin (BTC) briefly dipped to $102,000 on the Binance perpetual futures pair following Trump’s announcement of sweeping tariffs on Friday.
The Crypto Fear & Greed Index posted a “Greed” score of 71 when Bitcoin reached new highs on Monday. Source: Alternative.meOver the past 24 hours, approximately $19.27 billion worth of long and short positions have been liquidated across the crypto market, according to CoinGlass.
Crypto market is flashing strong “buying signal,” says analystIn an X post on Friday, Bitwise European head of research, Andre Dragosch, said that the company’s intraday crypto asset Sentiment Index just “generated a strong contrarian buying signal.”
“The index reached an intraday low of -2.8 standard deviations - its lowest level since the ‘Yen Carry Trade Unwind’ in the summer of 2024,” Dragosch said.
Bitwise’s intraday cryptoasset sentiment index is flashing a “strong contrarian buying signal.” Source: Andre DragoschThe last time the Crypto Fear & Greed Index was this low was April 16, shortly after Bitcoin tumbled to $77,000 amid uncertainty escalating around trade tensions.
Just days before, on April 9, Trump announced a 90-day pause on higher reciprocal tariffs, reverting the tariffs to the 10% baseline for most countries.
Earlier this week, the Index was in “Greed” territory after Bitcoin reached new highs of $125,100 on Monday.
Bitcoin’s recent highs didn’t lead to euphoriaHowever, Santiment analyst Brian Quinlivan pointed out on Friday that Bitcoin’s recent all-time highs didn’t generate the same level of enthusiasm on social media as previous all-time highs.
“It was like a modest, run-of-the-mill reaction from the crypto audience,” Quinlivan said in an interview with the Thinking Crypto podcast published to YouTube on Thursday, referring to the level of bullish comments across social media after Bitcoin reached new highs of $125,100 on Monday.
“Really wasn’t much of anything,” Quinlivan said. “It’s not nearly as euphoric as some of these previous ones,” he added.
Magazine: EU’s privacy-killing Chat Control bill delayed — but fight isn’t over
2025-10-11 06:086mo ago
2025-10-11 01:326mo ago
Wall Street Quietly Accumulates XRP Ahead of Potential ETF Approval
XRP has been maintaining a relatively stable price around $2.86, even as the broader cryptocurrency market experiences turbulence. Over the past 24 hours, the token has fluctuated between $2.75 and $2.88, showing signs of consolidation.
2025-10-11 06:086mo ago
2025-10-11 01:326mo ago
XRP Crashes 40%, Before Recovering, in Biggest One-Day Drop
XRP Crashes 40%, Before Recovering, in Biggest One-Day DropThe selloff drove price as low as $1.64 before a partial recovery to $2.36, with volumes surging 164% above the 30-day average.Updated Oct 11, 2025, 5:32 a.m. Published Oct 11, 2025, 5:32 a.m.
XRP collapsed as much as 42% in Friday’s trade, its sharpest one-day drop in recent years, as whales liquidated across major venues and futures open interest fell $150 million.
The selloff drove price as low as $1.64 before a partial recovery to $2.36, with volumes surging 164% above the 30-day average — a sign of forced deleveraging across corporate desks.
What to Know
• XRP fell from $2.82 to $2.36 between Oct 10, 01:00 and Oct 11, 00:00, posting a 16% daily loss.
• Intraday volatility peaked at 43%, with prices briefly wicking to $1.64 during high-frequency liquidation sweeps.
• Institutional futures open interest dropped from $9.0B to $8.85B as long liquidations hit $21M versus $2M shorts.
• 320M XRP transferred to exchange wallets in the past week, confirming whale distribution pressure.
• Late-session buying stabilized price near $2.35–$2.40, with accumulation volumes exceeding 12M in the final 15 minutes.
News Background
• Ripple’s ecosystem faces macro and structural stress: global trade tensions, diverging central-bank policy, and uncertainty over U.S. digital banking licenses.
• Ripple’s National Trust charter deadline passed on Oct 7, heightening regulatory risk premiums around XRP-linked institutional products.
• Despite the drawdown, on-chain data shows long-term holders adding below $2.40, suggesting value-based repositioning.
Price Action Summary
• XRP opened near $2.82 and sold off aggressively by mid-session, breaching key supports at $2.70 and $2.50.
• The heaviest liquidation occurred between 15:00–21:00 UTC, when hourly volume hit 817.6M.
• Low of $1.64 marked potential capitulation point; bounce to $2.36 capped at resistance around $2.84.
• The final 60 minutes (23:41–00:40) saw a stabilization move from $2.31 → $2.38 (+2%), with algos breaking $2.35 on sustained bids.
Technical Analysis
• Support: Established around $2.30–$2.35; extended downside risk to $2.22 if volume dries up.
• Resistance: Layered at $2.84–$2.90, with $3.05 as macro breakout trigger.
• Volume: Up 164% vs. 30-day average — capitulation-grade turnover.
• Trend: 75-day symmetrical triangle broken to downside; needs close above $2.90 to regain structure.
• Momentum: RSI levels near multi-month lows; volatility bands expanding, signaling potential base formation.
What Traders Are Watching
• Whether $2.30 support zone attracts sustained whale accumulation.
• Rebuild of open interest following $150M contraction in derivatives markets.
• Regulatory clarity post-Ripple charter review, and its impact on corporate adoption.
• Cross-asset spillover from BTC’s $125K rally — potential relief rotation back into XRP.
• Technical confirmation above $2.90 to invalidate short-term bearish bias.
STORY CONTINUES BELOW
More For You
Total Crypto Trading Volume Hits Yearly High of $9.72T
Sep 9, 2025
Combined spot and derivatives trading on centralized exchanges surged 7.58% to $9.72 trillion in August, marking the highest monthly volume of 2025
What to know:
Combined spot and derivatives trading on centralized exchanges surged 7.58% to $9.72 trillion in August, marking the highest monthly volume of 2025Gate exchange emerged as major player with 98.9% volume surge to $746 billion, overtaking Bitget to become fourth-largest platformOpen interest across centralized derivatives exchanges rose 4.92% to $187 billionView Full Report
Trump’s 100% tariff warning on China ignited a global sell-off that wiped out $16 billion in leveraged crypto longs and pushed Ethena’s USDe to a rare sub-$1 print.
What to know:
U.S. markets dropped sharply after President Trump threatened 100% tariffs on Chinese imports, causing global financial turmoil.The threat reignited trade war fears, leading to significant declines in Bitcoin, Ether and other digital assets, extending Friday's sell-off into morning Asia hours. The U.S. government shutdown has delayed economic data releases, adding to market uncertainty.Read full story
2025-10-11 06:086mo ago
2025-10-11 01:386mo ago
Will Cardano (ADA) Price Crash to 0 Amid Renewed U.S.–China Trade War?
Cardano price has taken a brutal hit in the past 48 hours, dropping over 9% daily and breaking below key support levels. This sharp move comes at the same time as escalating geopolitical and macroeconomic tensions, particularly the renewed U.S.–China trade war triggered by rare earth restrictions and 100% tariffs. The question investors are asking now is simple: could ADA really crash to 0, or is this fear exaggerated?
Cardano Price Prediction: Why Global Trade Wars Matter for ADA Price?At first glance, a U.S.–China rare earth standoff might feel unrelated to a blockchain project like Cardano. But here’s the connection: rare earths are essential for semiconductors, electric vehicles, and high-tech manufacturing. A supply shock drives inflation higher, worsens global risk sentiment, and pressures capital markets. When investors pull back from risk-on assets, cryptocurrencies like ADA are often the first to bleed.
The latest announcement of 100% tariffs has rattled equity markets, pushed risk aversion higher, and spilled directly into crypto. ADA’s sharp decline is not just technical selling—it reflects broader panic triggered by macro events.
Cardano Price Prediction: What the ADA Chart Is Really Saying?ADA/USD Daily Chart- TradingViewLooking at the daily chart, ADA has broken through the $0.75–$0.72 support zone, collapsing toward $0.66 at the time of writing. The Bollinger Bands show extreme expansion, meaning volatility is spiking. Price action has sliced below the middle band, turning momentum decisively bearish.
Key levels to watch now:
Immediate support sits around $0.65, where buyers are tentatively stepping in.If this level fails, the next demand zone is near $0.55, aligning with the lower Bollinger band extension.On the upside, ADA needs to reclaim $0.75 and eventually $0.81 to show recovery strength.The chart paints a picture of panic-driven selling. This is not a controlled downtrend but a capitulation-style move.
Cardano Price Prediction: Could ADA Price Really Crash to 0?Here’s the thing: no, ADA price is not going to zero. A crash to zero implies the complete collapse of the Cardano network, its ecosystem, and its utility. That’s not the case. What we’re seeing is a brutal risk-off correction amplified by global macro events.
However, the probability of ADA revisiting deeper lows—say $0.50 or even $0.40—has increased significantly if trade war escalation continues. Crypto markets thrive on liquidity, and tariffs, inflation, and rare earth supply shocks all reduce investor appetite for speculative assets. ADA is fundamentally solid but cannot escape the liquidity cycle.
Short-Term Prediction: More Pain Ahead?In the near term, $ADA is likely to remain under heavy pressure. As long as the U.S.–China dispute keeps rattling markets, every bounce risks turning into a bull trap. A retest of $0.55 is not only possible but probable if the broader selloff extends.
On the flip side, if trade talks unexpectedly stabilize or markets absorb the tariff shock faster than expected, $Cardano could bounce back toward $0.80. But until the $0.81 level flips from resistance to support, the bears are in control.
Long-Term Outlook: Survival, Not CollapseCardano is one of the few blockchain projects with an active development roadmap, real adoption cases in DeFi and governance, and a strong community. These fundamentals act as a safety net. ADA price may bleed in the short term, but the network is not disappearing.
Long-term investors should view the current crash as part of the broader crypto cycle influenced by macro shocks. Cardano price at $0.40–$0.50 would be painful, but it would also set up a long-term accumulation zone.
Final TakeawayADA is not crashing to zero. What we are witnessing is a macro-driven risk event pulling ADA into deeper bearish waters. If you’re trading, respect the $0.65 support and prepare for a possible $0.55 test. If you’re investing, understand that this is a storm caused by tariffs, rare earth shocks, and global uncertainty—not by the failure of Cardano itself.
📈 Want to Trade Cardano?Start now on Bitget: Sign Up Here
Check Live ADA Chart: ADA/USDT on Bitget
or You an check the Crypto Exchange Comparison.
2025-10-11 06:086mo ago
2025-10-11 01:506mo ago
Bitcoin Crash Sparks Largest Liquidation in Crypto History – $19B Gone and Counting
More than 1.6 million traders have been wrecked daily.
There’s no way to sugarcoat what happened in the cryptocurrency markets since Friday evening. Bitcoin’s price, for example, took one of its most painful nosedives in recent history, dumping from over $122,000 to $105,000 on some exchanges and even to as low as $101,000 on others.
The altcoins were obliterated as well, with massive double-digit price drops from the majority of them. Here’s what we know so far.
Valuermarket’s report classified the event as the “largest single-day liquidation in the history of digital assets.” The initial numbers of $250 million in an hour and $900 million on a 24-hour scale when BTC had dipped to $117,000 pale in comparison to what happened next.
Data from CoinGlass shows a violent picture of $19.30 billion wrecked in the span of a day. Naturally, longs represent the lion’s share, with nearly $17 billion. However, the crypto market’s minor recovery attempt since then has also harmed some short traders, with $2.5 billion in such liquidations.
The number of wrecked traders is off the charts as well. It typically remains around 200,000 during a bad liquidation event, but has now skyrocketed to over 1,660,000. That’s more than 1.6 million traders.
Liquidation Data from CoinGlass
The most obvious reason for this calamity was Trump’s actions on Friday evening when he threatened China with a new set of substantial tariffs after saying that Beijing had been lying for a long time.
The losses on Hyperliquid alone account for a big portion of the entire wipe-out. After all, the single-largest liquidation occured on Hyperliquid, with over $200 million gone on a ETH-USDT pair.
Bitcoin’s (BTC) Emotional Comeback: Data Shows Market Confidence Returning After Weeks of Fear
Analyst Insights: Bitcoin Could Drop More as Dollar Rebound Tightens Global Liquidity
I counted 1010 traders that are down $100k+ today and 206 traders that are down $1M+ today on Hyperliquid
358 of those accounts lost everything and have ~0 balance, including one person who lost all $19M+ in their account pic.twitter.com/aAHFwidXIG
— Conor (@jconorgrogan) October 10, 2025
Despite the majority of traders in losses, there are some that made significant profits. According to MLM, one whale closed 90% of their BTC short and fully closed their ETH short, profiting around $200 million in just a day.
In case you didn’t know – the BTC whale closed 90% of his BTC short and fully closed his ETH short, making around $190–$200M profit in just one day on Hyperliquid.
The crazy part is that he shorted another 9 figs worth of BTC and ETH minutes before the cascade happened. And this… pic.twitter.com/QhmUpesG0j
— MLM (@mlmabc) October 10, 2025
2025-10-11 06:086mo ago
2025-10-11 02:006mo ago
Zcash (ZEC) Price Added 350% in Two Weeks, Here Are Coins That Follow
Zcash (ZEC), a veteran privacy coin and the second biggest cryptocurrency in this space, mysteriously added about 350% in just two weeks. Here are some privacy coins that followed suit.
ZEC 350% price jump triggers privacy coins' rallyZcash (ZEC), the largest privacy coin after Monero (XMR), has routinely hit new price highs over $268. Two months ago, its price barely exceeded $40 on spot exchanges.
Image by CoinGeckoThe biggest rally happened in the last 14 days, when the price of Zcash (ZEC) followed a parabolic trajectory. The euphoria was supported by the endorsement of some key crypto opinion leaders, including Helius Founder Mert Mumtaz.
HOT Stories
The number of privacy coins followed the rally of the ZEC price. For instance, Railgun (RAIL) added over 185% in the last seven days.
Dash (DASH), another old-school privacy cryptocurrency, has jumped by 38% in 24 hours. The price of Firo (FIRO) doubled overnight and reached a multiyear high over $1.65.
"It's privacy season, better late than never": Expert Simon DedicTornado Cash's Torn and Monero (XMR), the largest privacy cryptocurrency, also registered strong rallies in recent weeks.
Simon Dedic, a founder and managing partner of blockchain consulting firm Moonrock Capital, is not surprised by the privacy coins finally rocketing:
So after more than 16 years of crypto, the masses have finally discovered privacy as an exciting use case lol. It’s privacy season, better late than never I guess.
Privacy coins represent a specific class of cryptocurrency assets that cannot be tracked: third parties are not able to recover transaction details, including the amount, time and addresses involved.
2025-10-11 06:086mo ago
2025-10-11 02:026mo ago
XRP Price Prediction Today as Market Witnesses ‘Covid-Like' 2020 Crash
The crypto market is witnessing one of its steepest declines in recent months, drawing comparisons to the infamous Covid crash of March 2020. Nearly $19 billion has been wiped off the global market in just 24 hours, with total capitalization now sitting at $3.73 trillion, down 9.93%.
A Bloodbath Across the MarketBitcoin (BTC) dropped 7.43% over the last day, currently trading near $112,517, while Ethereum (ETH) is down 12.93% to $3,799. Solana (SOL) was hit even harder, losing 17.45% to trade near $182.59.
Every altcoin has plunged, liquidating thousands of leveraged long positions in hours. Analysts have already begun comparing today’s crash to the early days of the pandemic market panic in 2020, when altcoins collapsed by more than 70% before a historic rebound.
Crypto analyst Ash Crypto commented that today’s situation feels “exactly like March 2020—when everyone thought it was over.” He said that after that crash, Bitcoin surged from $3,800 to $69,000, while Ethereum jumped from $90 to $4,800, and altcoins gained between 25x and 100x during the next bull cycle.
XRP Under Pressure: Breaking Key SupportAmong the top altcoins, XRP has been one of the most volatile. The token fell 14.53% in the past 24 hours to $2.41, with trading volume surging above $19.5 billion as panic selling intensified.
According to technical analysts, XRP’s current structure mirrors a bearish setup that has been developing since July. The token has been forming lower highs and lower lows, suggesting a potential continuation to the downside.
The token broke below a very important area of support around $2.70, which has held for months. The next target could be $2.40–$2.50, or even as low as $2.00 in the coming weeks.
This critical support region has served as a base since early August, bouncing XRP multiple times. However, the current sell-off appears to be stronger than previous pullbacks, confirming a descending triangle pattern that may trigger deeper declines.
Oversold but Opportunity Ahead?XRP’s daily and weekly charts are now deeply oversold, and historically, such conditions have preceded strong recoveries once selling pressure eases.
If history repeats itself, the “Covid-style” sell-off could set up the next major accumulation phase before a new bull leg. The analyst said that this is XRP’s last chance to regain the $2.70 level. Failure to do so could drag the price closer to $2.00.
Whether XRP follows the 2020 script again depends on its ability to hold above key support levels and whether Bitcoin stabilizes in the coming days.
Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.
Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.
Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.
2025-10-11 06:086mo ago
2025-10-11 02:056mo ago
Morgan Stanley abolishes restrictions on Bitcoin ETFs and breaks a taboo
Morgan Stanley, one of the world’s largest wealth managers, has just announced a historic decision: all its clients, including those with retirement accounts, can now invest in Bitcoin ETFs. A first for a major bank, which could accelerate the widespread adoption of digital assets.
In brief
Starting October 15, 2025, Morgan Stanley opens crypto investment through Bitcoin ETFs to all its clients, including retirement accounts.
Opening Bitcoin to all could boost institutional demand for BTC but also increase volatility in case of correction.
Morgan Stanley breaks down barriers and opens access to Bitcoin
Until now, access to cryptos at Morgan Stanley was reserved for an elite group: wealthy clients (over 1.5 million dollars in assets) and taxable accounts only. Starting October 15, 2025, everything will change. The bank will lift these restrictions, allowing all its clients – including those preparing for retirement – to invest in Bitcoin funds via BlackRock and Fidelity.
Why this turnaround? First, a regulatory change. Under the Trump administration, the United States softened its stance on cryptos, making their integration into traditional portfolios easier.
Next, growing demand. Clients, increasingly familiar with Bitcoin and Ethereum, are asking for diversified investment options.
Finally, competition. Fidelity and JPMorgan have already made the move, pushing Morgan Stanley to stay competitive.
The committee considers cryptocurrencies as a speculative but increasingly popular asset class
said Lisa Shalett, Chief Investment Officer for Wealth Management at Morgan Stanley, in an internal report cited by CNBC.
What consequences for the crypto market?
This Morgan Stanley decision could have a domino effect on the entire crypto and financial sector.
Accelerated massive adoption
With millions of clients now eligible, demand for Bitcoin ETFs should explode. Other banks (Goldman Sachs, Bank of America) might follow, lest they miss the crypto train.
Pressure on regulators
US authorities (SEC, Department of Labor) will need to clarify their position on integrating cryptos into retirement plans, especially after past warnings about the risks of these assets.
A test for market resilience
If institutional investors like Morgan Stanley allocate funds massively to crypto, it could stabilize prices long term. Or amplify corrections in times of crisis.
Will Bitcoin soar thanks to Morgan Stanley?
The opening of Morgan Stanley retirement and regular client accounts to crypto funds could well act as a catalyst for Bitcoin. With millions of new institutional and retail investors now eligible, demand could significantly increase, supporting prices mid-term.
However, this massive adoption also comes with a risk of increased volatility: if markets correct, massive sell-offs could amplify the declines. Short term, the psychological effect could dominate, with a speculative rise in Bitcoin. But stability will depend on the balance between adoption and regulation.
The Morgan Stanley announcement is a historic turning point. For the first time, a major bank widely opens the doors to crypto for all its clients. An inevitable evolution or a risky bet? If the movement confirms itself, we could witness the gradual integration of digital assets and particularly BTC into traditional finance, which so far underestimates Bitcoin.
Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.
Join the program
A
A
Lien copié
Eddy S.
The world is evolving and adaptation is the best weapon to survive in this undulating universe. Originally a crypto community manager, I am interested in anything that is directly or indirectly related to blockchain and its derivatives. To share my experience and promote a field that I am passionate about, nothing is better than writing informative and relaxed articles.
DISCLAIMER
The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.
2025-10-11 05:086mo ago
2025-10-11 00:406mo ago
SOLT: A Tactical Way To Double Solana's Moves If You Know The Risks
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Original article written in Spanish, translated using OmegaT (not AI).
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-10-11 05:086mo ago
2025-10-11 01:006mo ago
India's Mahindra Expands in South Africa as Tariffs Hit Autos
US President Donald Trump's trade policy is fueling the South-South trade and one example of this is the growing automotive trade between India and South Africa. Indian automaker Mahindra is boosting its capacity at its plant in Durban to capitalize on growing demand for bakkies in the continent.
2025-10-11 05:086mo ago
2025-10-11 01:026mo ago
Six Reasons To Ride Apple's Rally Cautiously And Why Continue To Use APLY
SummaryApple remains resilient amid tariff pressures, with strong free cash flow and stable profit margins demonstrating durable pricing power.APLY, a conservative covered call ETF on AAPL, has captured ~20% of AAPL's ~27% rally, offering defensive upside and drawdown protection.AAPL consistently beats EPS expectations, with upcoming earnings likely to show strong growth driven by new product launches and services expansion.Despite positive momentum, a defensive approach like APLY is advised for those wary of valuation risks, as it balances income, upside, and risk mitigation. Kunlathida Petchuen/iStock via Getty Images
In June 2025, I did not have a strong directional view on Apple (NASDAQ:AAPL). I ended up recommending the YieldMax AAPL Option Income Strategy ETF (NYSEARCA:APLY), a conservative call writing
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Recommended For You
2025-10-11 04:086mo ago
2025-10-10 23:146mo ago
Energy Transfer: Powering The AI Boom And Paying An 8% Yield
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in ET over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-10-11 04:086mo ago
2025-10-10 23:156mo ago
FLR INVESTOR DEADLINE: Fluor Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
, /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Fluor Corporation (NYSE: FLR) securities between February 18, 2025 and July 31, 2025, both dates inclusive (the "Class Period"), have until Friday, November 14, 2025 to seek appointment as lead plaintiff of the Fluor class action lawsuit. Captioned Maglione v. Fluor Corporation, No. 25-cv-02496 (N.D. Tex.), the Fluor class action lawsuit charges Fluor as well as certain of Fluor's top current and former executives with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the Fluor class action lawsuit, please provide your information here:
You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected].
CASE ALLEGATIONS: Fluor provides engineering, procurement, and construction; fabrication and modularization; and project management services. Fluor's infrastructure projects include work on the Gordie Howe International Bridge ("Gordie Howe"), as well as the Interstate 365 Lyndon B. Johnson ("I-635/LBJ") and Interstate 35E ("I-35") highways in Texas, according to the complaint.
The Fluor class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) costs associated with the Gordie Howe, I-635/LBJ, and I-35 projects were growing because of, among other things, subcontractor design errors, price increases, and scheduling delays; (ii) the foregoing, as well as customer reduction in capital spending and client hesitation around economic uncertainty, was having, or was likely to have, a significant negative impact on Fluor's business and financial results; and (iii) accordingly, Fluor's financial guidance for fiscal year 2025 was unreliable and/or unrealistic, the effectiveness of Fluor's risk mitigation strategy was overstated, and the impact of economic uncertainty on Fluor's business and financial results was understated.
The Fluor class action lawsuit further alleges that, on August 1, 2025, Fluor reported second quarter 2025 non-GAAP earnings per share of $0.43, missing consensus estimates by $0.13, and revenue of $3.98 billion, representing a 5.9% year-over-year decline and missing consensus estimates by $570 million. Defendants blamed these disappointing results on, among other things, growing costs in multiple infrastructure projects due to subcontractor design errors, price increases, and scheduling delays, as well as reduced capital spending by customers, the complaint alleges. Fluor also provided a negatively revised financial outlook for fiscal year 2025, citing "client hesitation around economic uncertainty and its impact on new awards and project delays and results for the quarter." The complaint also alleges that Fluor's CEO, defendant James R. Breuer, further disclosed during an earnings call that the infrastructure projects that had negatively impacted Fluor's second quarter 2025 results were the Gordie Howe, I-635/LBJ, and I-35 projects. Following this news, the price of Fluor stock fell by more than 27%, according to the Fluor class action lawsuit.
THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Fluor securities during the Class Period to seek appointment as lead plaintiff in the Fluor class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Fluor class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Fluor class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Fluor class action lawsuit.
ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-10-11 04:086mo ago
2025-10-10 23:486mo ago
Snap Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Snap Inc. - SNAP
, /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have untilOctober 20, 2025 to file lead plaintiff applications in a securities class action lawsuit against Snap Inc. (NYSE: SNAP), if they purchased the Company's securities between April 29, 2025 to August 5, 2025, inclusive (the "Class Period"). This action is pending in the United States District Court for the Central District of California.
What You May Do
If you purchased securities of Snap and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-snap/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by October 20, 2025.
About the Lawsuit
Snap and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On August 5, 2025, the Company announced its financial results for the second quarter of fiscal 2025, disclosing a deceleration in advertising revenue growth due to "an issue related to our ad platform, the timing of Ramadan and the effects of the de minimis changes."
On this news, the price of Snap's shares fell from a closing price of $9.39 per share on August 5, 2025 to $7.78 per share on August 6, 2025, a decline of about 17.15% in the span of just a single day.
The case is Abdul-Hameed v. Snap, Inc., et al., No. 25-cv-07844.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
2025-10-11 04:086mo ago
2025-10-10 23:546mo ago
Molina Healthcare Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Molina Healthcare, Inc. - MOH
, /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have untilDecember 2, 2025 to file lead plaintiff applications in a securities class action lawsuit against Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE: MOH), if they purchased or otherwise acquired the Company's securities between February 5, 2025 and July 23, 2025, inclusive (the "Class Period"). This action is pending in the United States District Court for the Central District of California.
What You May Do
If you purchased securities of Molina and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-moh/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by December 2, 2025.
About the Lawsuit
Molina and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On July 23, 2025, the Company reported its financial results for the second quarter ended June 30, 2025 and cut its full-year 2025 earnings guidance, disclosing that "GAAP net income was $4.75 per diluted share for the second quarter of 2025, a decrease of 8% year over year" and it "now expects its full year 2025 adjusted earnings to be no less than $19.00 per diluted share," due to a "challenging medical cost trend environment," including "utilization of behavioral health, pharmacy, and inpatient and outpatient services."
On this news, the price of Molina's shares fell $32.03, or 16.84%, to close at $158.22 per share on July 24, 2025, on unusually heavy trading volume.
The case is Hindlemann v. Molina Healthcare, Inc., et al., No. 2:25-cv-09461.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-10-11 03:086mo ago
2025-10-10 21:396mo ago
DKM Loads Up on QQQ With 7,900 Shares Worth $4.8 Million
On October 10, 2025, DKM Wealth Management, Inc. disclosed a new position in Invesco QQQ Trust, Series 1, acquiring 7,935 shares for an estimated $4.76 million in Q3 2025.
What happenedAccording to a filing with the U.S. Securities and Exchange Commission dated October 10, 2025, DKM Wealth Management, Inc. initiated a position in Invesco QQQ Trust, Series 1 (QQQ -3.47%), purchasing approximately 7,935 shares in Q3 2025. The estimated transaction value is $4,763,936 in Q3 2025. This brings the fund’s total QQQ position to $4.76 million, with no prior holding reported last quarter.
What else to knowThis is a new position for the fund, now accounting for 3.8% of DKM Wealth Management, Inc.’s $124.58 million in reportable U.S. equity assets in Q3 2025.
Top holdings after the filing:
(NASDAQ:TBLD): $18.72 million (15.0% of AUM) in Q3 2025(NYSEMKT:TCAF): $14,341,015 (11.5113% of AUM) as of September 30, 2025(NYSE:SOR): $12.86 million (10.3% of AUM) in Q3 2025(NYSEMKT:GRNY): $9.22 million (7.4% of AUM) in Q3 2025(NYSEMKT:ITOT): $7,186,455 (5.7685% of AUM) as of September 30, 2025As of October 9, 2025, shares of Invesco QQQ Trust, Series 1 were priced at $610.70, up 23.84% for the year through October 9, 2025, outperforming the S&P 500 by 8.38 percentage points
Company overviewMetricValueAUM$385.76 BillionPrice (as of market close 2025-10-09)$610.70Dividend yield0.48%1-year total return23.84%Company snapshotThe investment strategy seeks to track the performance of the NASDAQ-100 Index®.
The portfolio is periodically rebalanced to maintain alignment with the index.
The fund is structured as a trust.
Invesco QQQ Trust offers investors targeted exposure to the NASDAQ-100 Index. The fund’s strategy uses periodic rebalancing to closely mirror index composition and weights.
Foolish takeDKM Wealth Management opened a new position in Invesco’s popular QQQ Trust in Q3 2025, to the tune of $4.8 million and over 7,900 shares. Because QQQ tracks the NASDAQ-100, it gives DKM Wealth Management and other investors a more balanced exposure to tech stocks without nearly as much risk as would be present in investing in individual technology companies.
This has pros and cons, since any individual tech holding can suddenly become a hot commodity and its value balloon dramatically in the current market environment. However, by selecting a basket of tech giants, investors can largely avoid the dramatic ups and downs involved with this sector, and are protected from the more serious losses that can also be present here.
QQQ is an ETF that’s frequently and sometimes aggressively traded, more preferred by active traders than its very similar cousin, QQQM. QQQ also has higher liquidity, which may be preferred by DKM if the fund feels that this is a shorter term investment, rather than a permanent portfolio balancing move. It can certainly be held long term like QQQM typically is, but it has a higher expense ratio and a higher per share price. Don’t expect this to be a long-term move.
Glossary13F reportable assets: Assets that U.S. institutional investment managers must disclose quarterly to the SEC on Form 13F.
Assets under management (AUM): The total market value of investments managed on behalf of clients by a fund or firm.
Position: The amount of a particular security or investment held by an investor or fund.
Trust (fund structure): An investment fund organized as a legal trust, often holding assets on behalf of investors.
Periodic rebalancing: Adjusting a portfolio’s holdings at set intervals to maintain target asset allocations or index alignment.
Dividend yield: The annual dividend income from an investment, expressed as a percentage of its current price.
Total return: The investment's price change plus all dividends and distributions, assuming those payouts are reinvested.
NASDAQ-100 Index®: A stock market index comprising 100 of the largest non-financial companies listed on the NASDAQ exchange.
Outperforming: Achieving a higher return than a benchmark index or comparable investment over a given period.
Market value: The current total value of a holding, calculated as the share price multiplied by the number of shares owned.
Kristi Waterworth has positions in Invesco NASDAQ 100 ETF. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
2025-10-11 03:086mo ago
2025-10-10 22:116mo ago
3 Defensive Stocks to Watch as Trade Tensions Resurface: GILD, JNJ, KR
Resurfaced tensions between the U.S. and China caught the market off guard in Friday’s trading session, with the S&P 500 and Nasdaq falling over 2% on news that President Trump plans to impose an additional 100% tariff on Chinese goods starting November 1st.
Notably, President Trump stated the move was prompted by China taking an “extraordinarily aggressive” position in what had been ongoing trade talks by announcing new export controls on the U.S. that will take effect next month.
With investors being on edge as the world’s two largest economies go head-to-head again, seeking out stocks that can offer defensive safety in the portfolio may be necessary.
Top Performing Medical Stocks The medical sector had been at the forefront of defensive positions earlier in the year when President Trump’s Liberation Day Tariffs rocked the broader market, with Gilead Sciences (GILD - Free Report) and Johnson & Johnson (JNJ - Free Report) being able to hold onto some of these exhilarating gains.
GILD and JNJ shares are hovering near their 52-week highs and are still up more than +25% year to date, respectively. Enthusiasm for their drug pipelines has been magnified by increased probability, as Gilead Sciences has a stronghold in developing treatments for HIV and liver diseases, while Johnson & Johnson has a robust portfolio across immunology, oncology, neuroscience, and other therapeutic areas.
Image Source: Zacks Investment Research
Also attracting investors have been Gilead Sciences and Johnson & Johnson’s respectable dividends, which are both around 2.7%, topping the Zacks Medical sector’s average of 1.47% and the S&P 500’s average of 1.1%.
Image Source: Zacks Investment Research
Kroger’s Value as a Retail Grocery Leader As one of the largest grocery chains in the U.S., investors have shown a tendency to flock to Kroger's (KR - Free Report) stock for defensive safety as well. While Kroger stock lost some of its YTD gains when tariff concerns subsided, KR is still up a respectable +13% in 2025.
Amid a resurgence in market volatility, Kroger’s value may take center stage with KR trading at a reasonable 14X forward earnings multiple and well under the preferred level of less than 2X sales.
Image Source: Zacks Investment Research
Seeing steady top and bottom line expansion, Kroger stock stands out with an overall “A” VGM Zacks Style Scores grade for Value, Growth, and Momentum. Plus, Kroger also offers an annual dividend yield of over 2%.
Even better, Kroger’s 28% payout ratio suggests there is plenty of room to raise its dividend in the future, with KR having an impressive annualized dividend growth rate of 15.24% in the last five years.
Image Source: Zacks Investment Research
Bottom Line Building their reputations as viable defensive investments, Gilead Sciences, Johnson & Johnson, and Kroger stock all land a Zacks Rank #3 (Hold) at the moment. That said, these stocks will likely attract investors if markets continue to pull back, as their operations are deemed essential regardless of economic uncertainty.
SummaryMister Car Wash shares have dropped 35% YTD, but the business remains stable with growing sales, EBITDA, and a strong subscriber base.MCW's subscription model, leading market share, and strong balance sheet provide competitive advantages in a slowing but still competitive car wash industry.At just 7x 2026 EBITDA and 9x free cash flow, MCW appears undervalued, with a fair value estimate of $7-8 per share (45-65% upside).Despite risks from competition and concentrated ownership, I rate MCW a 'Buy' due to its discounted valuation and resilient business model. Alones Creative/iStock via Getty Images
Shares of Mister Car Wash (NASDAQ:MCW) have been battered, declining 35% year-to-date, significantly underperforming the Russell 2000 index (IWM) which has increased 7.5% over the same period. While Mister Car
Analyst’s Disclosure:I/we have a beneficial long position in the shares of MCW either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Also long DRVN
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Recommended For You
About MCW Stock
More on MCW
Related Stocks
MCW
-
Trending Analysis
Trending News
2025-10-11 03:086mo ago
2025-10-10 22:466mo ago
SAGA Metals Announces Closing of Fully Subscribed Non-Brokered Private Placement and Provides Corporate Update
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Oct. 10, 2025 (GLOBE NEWSWIRE) -- SAGA Metals Corp. ("SAGA" or the "Company") (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company focused on critical minerals, is pleased to announce the closing of its previously announced non-brokered private placement pursuant to which the Company raised aggregate gross proceeds of C$2,988,024.64 (the “Offering”).
2025-10-11 03:086mo ago
2025-10-10 22:486mo ago
JABS: Investment Grade ABS Securities Via This Fund
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-10-11 03:086mo ago
2025-10-10 22:526mo ago
Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK
, /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have untilNovember 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against Cytokinetics, Incorporated (NasdaqGS: CYTK), if they purchased or otherwise acquired the Company's securities between December 27, 2023 and May 6, 2025, inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District of California.
What You May Do
If you purchased securities of Cytokinetics and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-cytk/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by November 17, 2025.
About the Lawsuit
Cytokinetics and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On March 10, 2025, the Company disclosed that the U.S. Food and Drug Administration ("FDA") had decided not to convene an advisory committee meeting to review the Company's New Drug Application ("NDA") for its aficamten product. Then, on May 6, 2025, the Company disclosed that it had held multiple pre-NDA meetings with the FDA discussing safety monitoring and risk mitigation but chose to submit the NDA without a Risk Evaluation and Mitigation Strategy, instead relying on labeling and voluntary education materials.
On this news, the price of Cytokinetics' shares fell, closing at $33.04 per share on May 7, 2025.
The case is Seidman v. Cytokinetics, Incorporated, et al., No. 25-cv-07923.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Jasper To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Jasper between November 30, 2023 and July 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ: JSPR) and reminds investors of the November 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) Jasper lacked the controls and procedures necessary to ensure that the third-party manufacturers on which it relied were manufacturing products in full accordance with cGMP regulations and otherwise suitable for use in clinical trials; (ii) the foregoing failure increased the risk that results of ongoing studies would be confounded, thereby negatively impacting the regulatory and commercial prospects of the Company's products, including briquilimab; (iii) the foregoing increased the likelihood of disruptive cost-reduction measures; (iv) accordingly, the Company's business and/or financial prospects, as well as briquilimab's clinical and/or commercial prospects, were overstated; and (v) as a result, Defendants' public statements were materially false and misleading at all relevant times.
On July 7, 2025, Jasper issued a press release reporting updated data from the BEACON Study. The press release stated that "[r]esults from the 240mg Q8W and the 240mg followed by 180mg Q8W dose cohorts appear to be confounded by an issue with one drug product lot used in those cohorts, with 10 of the 13 patients dosed with drug from the lot in question," that "[t]he Company is investigating the drug product lot in question and expects to have the results of that investigation in the coming weeks," and that Jasper was "taking steps to ensure that drug product from the lot in question is returned to the Company and that sites have drug product from other lots to continue dosing." Further, the press release revealed that the Company "has also determined that the drug product lot in question was used to treat participants enrolled in the ETESIAN [Study]. As a result, and in order to focus resources on advancing briquilimab in CSU, the Company is halting the study and pausing development in asthma." Finally, the press release stated that "the Company is halting development in SCID" and, contrary to its prior representation of having a strong balance sheet and a cash runway extending "through the third quarter of 2025," that Jasper "will be implementing a number of other cost cutting measures including a potential restructuring, to extend runway and reduce expenses."
On this news, Jasper's stock price fell $3.73 per share, or 55.1%, to close at $3.04 per share on July 7, 2025.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Jasper's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Jasper Therapeutics, Inc. class action, go to www.faruqilaw.com/JSPR or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
SOURCE Faruqi & Faruqi, LLP
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
2025-10-11 02:086mo ago
2025-10-10 20:126mo ago
MLTX INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In MoonLake To Contact Him Directly To Discuss Their Options
If you suffered significant losses in MoonLake stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against MoonLake Immunotherapeutics ("MoonLake" or the "Company") (NASDAQ: MLTX).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
Moonlake Immunotherapeutics saw its shares plummet over 80% on Monday after disappointing results from two late-stage trials of its experimental drug, sonelokimab, for hidradenitis suppurativa. While one study showed a statistically significant improvement over placebo, the margin of benefit fell short of investor expectations. The second trial failed to meet its primary endpoint entirely, with the company citing an unexpectedly high placebo response. The underwhelming data has cast doubt on the drug's regulatory path and commercial potential, prompting skepticism from analysts and a sharp market sell-off.
To learn more about the MoonLake investigation, go to www.faruqilaw.com/MLTX or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.comv). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
SOURCE Faruqi & Faruqi, LLP
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
2025-10-11 02:086mo ago
2025-10-10 20:136mo ago
Apple Reorganizes Health and Fitness Divisions Ahead of Former COO's Retirement
Apple is reportedly reorganizing some of its divisions as the retirement of former Chief Operating Officer Jeff Williams nears.
The company will move its health and fitness divisions and place them under the oversight of its services chief, Eddy Cue, Bloomberg reported Friday (Oct. 10), citing unnamed sources.
In addition, the Apple Watch operating system will now be overseen by the company’s head of software engineering, Craig Federighi, according to the report.
Apple did not immediately reply to PYMNTS’ request for comment.
According to the Bloomberg report, both Cue and Federighi have decades of experience at the company, helped launch some of its biggest products and have been gaining influence.
The report added that Apple wanted to combine its health and fitness divisions’ efforts and that it plans to launch a new subscription service called Health+. The Health+ service will provide users with personalized recommendations on nutrition, exercise and sleep with the help of an artificial intelligence-powered assistant, per the report.
Advertisement: Scroll to Continue
Apple announced in July that Williams would retire later this year to spend more time with friends and family.
The company said at the time that Williams would transition his role as COO later that month to Apple Senior Vice President of Operations Sabih Kahn. It said he would continue reporting to Apple CEO Tim Cook and overseeing the company’s design team, Apple Watch, and health initiatives, and then would retire later in the year.
Cook said in the July press release that Williams had “helped to create one of the most respected global supply chains in the world; launched the Apple Watch and overseen its development; architected Apple’s health strategy; and led our world-class team of designers with great wisdom, heart and dedication.”
Bloomberg reported in March that Apple was working on an AI agent that can dispense health advice and that the project marked the company’s latest and perhaps strongest push into the health field.
During Apple’s third quarter earnings report in July, the company said the revenues of its wearables, home and accessories category, which includes Apple Watch, fell 9% to $7.4 billion. Services revenue was up 13% to $27.4 billion.
2025-10-11 02:086mo ago
2025-10-10 20:156mo ago
AI Chatbots Could Redefine Shopping. This Retailer Is Well-Positioned to Benefit, Cowen Says.
Too many questionable start-ups went public during the pandemic, when the sector was hot. Now, after over four years of pain, the weak have failed, rates are falling, and M&A looks to be on the upswing.
2025-10-11 02:086mo ago
2025-10-10 20:276mo ago
J.B. Hunt, United earnings should give us a read on the economy, says Jim Cramer
CNBC's Jim Cramer discusses the market sell-off following President Trump's announcement of an additional 100% tariff on Chinese imports, the stocks he's watching and more.
2025-10-11 02:086mo ago
2025-10-10 20:306mo ago
Revival Gold Provides Update on the Company's Annual and Special Meeting
TORONTO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) wishes to update its shareholders on details regarding the Company's upcoming annual general and special meeting, which is to be held at the offices of Peterson McVicar LLP, at 110 Yonge Street, Suite 1601, Toronto, ON M5C 1T4 on November 20, 2025 at 10:00 A.M. (Toronto time) ("Meeting"). The Company confirms the availability of its meeting materials and wishes to advise its shareholders, due to the Canada Post mail strike, of alternative ways to vote their shares for the Meeting.
2025-10-11 02:086mo ago
2025-10-10 20:336mo ago
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and reminds investors of the October 21, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) HaloMD was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (2) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process were unsustainable; (3) in addition, the Company overstated the extent to which it had remediated, and/or its ability to remediate, the material weaknesses in its internal controls over financial reporting; (4) as a result, the Company was unable to effectively account for the treatment of certain of its stock based compensation obligations; (5) as a result, Nutex improperly calculated these stock based compensation obligations as equity rather than liabilities; (6) the foregoing increased the risk that the Company would be unable to timely file certain financial reports with the United States Securities and Exchange Commission ("SEC"); (7) accordingly, Nutex's business and/or financial prospects were overstated; and (8) as a result, Defendants' public statements were materially false and misleading at all relevant times.
On July 22, 2025, Blue Orca Capital ("Blue Orca") issued a short report on Nutex. The Blue Orca report alleges, among other things, that Nutex faces litigation risk due to its relationship with HaloMD, a third-party vendor that was recently sued for engaging in a "coordinated fraudulent scheme" to take millions from insurance companies on behalf of healthcare billing clients.
Following publication of the Blue Orca report, Nutex's stock price fell $11.18 per share, or 10.05%, to close at $100.01 per share on July 22, 2025.
On July 24, 2025, Nutex issued a press release responding to the Blue Orca Report, stating that it "strongly disagrees with the allegations in the report" and that it "expects to provide related updates in its upcoming earnings release and Form 10-Q for the second quarter of 2025 due on or before August 14, 2025."
However, after the market closed on August 14, 2025, Nutex announced that it would "delay filing its Form 10-Q for the period ending June 30, 2025", citing "non-cash accounting adjustments related to the treatment of stock-based compensation obligations for certain under-construction and ramping hospitals, as disclosed in previous filings."
When Nutex failed to rebut the allegations of the Blue Orca Report, the Company's stock price fell $18.22 per share, or 16.39%, to close at $92.91 per share on August 15, 2025.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Nutex's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Nutex Health class action, go to www.faruqilaw.com/NUTX or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
SOURCE Faruqi & Faruqi, LLP
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - Newpath Resources Inc. (CSE: PATH) (FSE: 0MZ) (OTC Pink: RDYFF) ("Newpath" or the "Company") announces that Douglas Turnbull has resigned as Chief Operating Officer of the Company, effective immediately, to pursue another professional opportunity. Mr. Turnbull has been a key member of the Company's executive team, providing invaluable leadership and operational oversight during a pivotal period of growth and development.
2025-10-11 02:086mo ago
2025-10-10 20:586mo ago
NU E Power Corp. Closes Strategic Acquisition of Blu Dot Systems Inc.
October 10, 2025 8:58 PM EDT | Source: Nu E Corp.
Calgary, Alberta--(Newsfile Corp. - October 10, 2025) - Nu E Power Corp. (CSE: NUE) (OTC Pink: NUEPF) (the "Company" or "Nu E") is pleased to announce that it has completed the acquisition (the "Acquisition") of 100% of the issued and outstanding common shares of Blu Dot Systems Inc. ("Blu Dot").
Pursuant to Acquisition, the Company acquired all of the issued and outstanding common shares of Blu Dot in consideration for the issuance of one (1) common share of Nu E (the "Nu E Shares") for each one (1) common share of Blu Dot (a "Blu Dot Share") held by each Blu Dot shareholder.
Nu E issued an aggregate 29,500,000 Nu E Shares in connection with the Acquisition. The Acquisition is subject to final approval from the Canadian Securities Exchange (the "CSE") The issuance of Nu E Shares, in connection with the Acquisition are subject to a 4 month resale restriction in accordance with applicable securities laws and the policies of the CSE. There was no finder's fee payable on closing of the Acquisition.
For more information on the Acquisition, please see the news releases dated April 15, 2025 and June 14, 2025 available on the Company's SEDAR+ profile at www.sedarplus.ca.
Governance and Shareholder Protections
The Acquisition was a "related party transaction" under Multilateral Instrument 61-101 — Protection of Minority Security Holders in Special Transactions ("MI 61-101") as a director and officer of Nu E is also a director, officer and/or shareholder of Blu Dot. The director and officer owned, directly or indirectly, 3,869,140 Blu Dot Shares and received an aggregate of 3,869,140 Nu E Shares pursuant to the Acquisition.
MI 61-101 requires that an issuer obtain approval of a majority of the disinterested shareholders as well as a formal valuation for a transaction that constitutes a related party transaction, absent an exemption from such requirements. The issuance of Nu E Shares to a related party will be considered a "related party transaction" within the meaning of MI 61-101 but such transaction is exempt from the valuation requirement of MI 61-101 as the Nu E Shares are not listed on a specified market, and from the minority shareholder approval requirements of MI 61-101 in that the fair market value of the consideration of the Nu E Shares issued to the related party did not exceed 25% of Nu E's market capitalization.
About Nu E Power Corp.
Nu E Power Corp. is a green energy company focused on the developing, construction, and operating clean and renewable energy infrastructure across North America. The Company has a partnership with Low Carbon Canada Solar Limited, a subsidiary of the UK based renewables major, Low Carbon Investment Management Ltd. To facilitate non-dilutive investment into the Company with the goal of developing up to 2GW of renewable energy projects in Canada by 2030.
Contact Information
For more information, please contact:
The Canadian Securities Exchange (operated by CNSX Markets Inc.) has neither approved nor disapproved of the contents of this press release.
This press release contains statements which constitute "forward‐looking information" within the meaning of applicable Canadian securities laws. Forward‐looking information is often identified by the words "may," "would," "could," "should," "will," "intend," "plan," "anticipate," "believe," "estimate," "expect" or similar expressions. In particular, this news release contains forward-looking information in relation to the Acquisition. There can be no assurance that such information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such information. Readers are cautioned that forward‐looking information is not based on historical facts but instead reflects the Company's management's expectations, estimates or projections concerning the business of the Company's future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. These assumptions include, CSE acceptance and market acceptance of the Acquisition; the Company's current and initial understanding and analysis of its projects; the Company's general and administrative costs remaining constant; and market acceptance of the Company's business model, goals and approach. Although the Company believes that the expectations reflected in such forward‐looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements. Among the key factors that could cause actual results to differ materially from those projected in the forward‐looking information are the following: changes in Nu E's business, general economic, business and political conditions, including changes in the financial markets; decreases in the prevailing prices for products in the markets that the Company operates in; adverse changes in applicable laws or adverse changes in the application or enforcement of current laws; regulations and enforcement priorities of governmental authorities; compliance with government regulation and related costs; and other risks described in the Listing Statement of Nu E posted on SEDAR+. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward‐looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward‐looking information except as otherwise required by applicable law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/270104
2025-10-11 02:086mo ago
2025-10-10 21:006mo ago
NY Artisinal Initiates Coverage of LuxUrban Hotels, Launches Independent Investigation into Financial Disclosures and Legal Filings
Los Angeles, CA, Oct. 10, 2025 (GLOBE NEWSWIRE) -- NY Artisinal, a New York–based independent research and investigative analysis firm, today announced the initiation of formal coverage of LuxUrban Hotels Inc., with a comprehensive review underway into the company’s financial disclosures, contractual practices, and pending litigation.
This investigation is part of NY Artisinal’s Ongoing Corporate Transparency Program, which focuses on identifying discrepancies and risk signals in high-growth sectors where public perception and financial reality may diverge.
LuxUrban Paid Its Workers in Full — Even as NYC Withheld $8 Million. Now Bankruptcy Could Be Its Comeback, Not Its Collapse.
LuxUrban Hotels wasn’t supposed to fail.
The fast-scaling hospitality startup had engineered one of the industry's most compelling business models: taking over underutilized hotels, turning them into short-term rentals, and doing it all without owning a single building.
Investors bought in — hard. At its peak, LuxUrban was valued at nearly $300 million, with an enterprise value above $500 million. It was lean, profitable, and fast-moving.
Then New York City stepped in.
Amid the city’s migrant housing crisis, LuxUrban became one of several companies contracted to provide emergency accommodations. But as the crisis deepened, the city fell behind — eventually withholding over $8 million in reimbursements.
Rather than lay off staff or stall operations, LuxUrban kept paying workers 115% of their wages, hoping payments would come through.
They never did. Bank accounts were frozen. Contracts evaporated. And now, the company once hailed as a next-gen hospitality unicorn is filing for Chapter 11 — not to die, but to survive.
When innovation met the wrong system
LuxUrban’s management thought they were helping.
At the height of the crisis, the company converted a Midtown property — the now-notorious Hotel 46 — into temporary housing for asylum seekers under contracts administered by the Hotel Association of New York City (HANYC) and the Department of Homeless Services (DHS).
It should have been a win-win: a fast, flexible example of public–private partnership in action.
Instead, it triggered a financial freefall.
According to legal filings reviewed by Business Insider, LuxUrban is owed more than $8 million, plus damages, from HANYC and DHS for reimbursements that never came. Those missing funds covered everything from payroll to food and security — costs the company paid directly out of its own reserves for nearly two years with no money in return.
At Hotel 46 alone, LuxUrban spent over $1.5 million on wages and essential operations. Across its portfolio, it absorbed another $5 million in union overages, bond drawdowns, and penalties that compounded when City reimbursements failed to arrive.
_____
The city payments that never came — and the 115% penalties that did
When reimbursements stalled, LuxUrban kept paying its workers anyway. Under strict union and Independent Workers Agreement (IWA) rules, even a payroll delay of a few hours triggered fines of up to 115% of wages.
That meant workers didn’t just get paid — they got paid extra, with an estimated $5 million in penalties flowing directly into their pockets across hotels that reported temporary wage delays.
LuxUrban covered every dollar of those payments out of pocket while waiting for City reimbursements that never came.
“The workers got every penny — and then some,” said a labor expert and legal counsel for large companies operating under collective bargaining agreements familiar with the program. “LuxUrban kept everyone employed and overpaid per contract while the City sat on the bill. The system punished performance.”
_____
From Chapter 11 to second chances
LuxUrban’s 2025 Chapter 11 filing drew harsh headlines and little sympathy.
But bankruptcy isn’t always failure. In this case, it may be the reset that exposes how bureaucracy, financial pressure, and opportunistic counterparties — not poor management — brought the company down.
A motion under 11 U.S.C. § 1104(a) seeks to appoint an independent Chapter 11 trustee to consolidate the estate and pursue claims that could total tens of millions of dollars.
If approved, that trustee would oversee litigation and recovery efforts involving:
• HANYC and DHS — the $8 million-plus in unpaid reimbursements.
• Tuscany Legacy Leasing & St. Giles Hotels — alleged to have granted a long-term lease it didn’t hold and later used that lease to trigger a Confession of Judgment that froze LuxUrban’s online-travel-agency and credit-card receivables, effectively choking off cash flow.
• Wyndham Hotels & Resorts — damages tied to a terminated brand partnership.
• Cloudbeds Inc. — questions surrounding financing fees and the recognition of liens and payment priorities that are now being reviewed by legal counsel.
• Expedia Group, Tuscany Legacy Leasing, and certain merchant-cash-advance lenders — cited in filings as having imposed restrictions on OTA and receivable transfers that, according to restructuring experts, further tightened liquidity and are being examined for whether they had contractual or legal authority to do so.
• Media entities, particularly Bisnow — whose reporting is now the subject of a formal legal review by retained counsel evaluating whether certain Bisnow articles were coordinated with short sellers to influence perception and trading activity.
Legal experts retained to evaluate these matters confirm that evidence is being reviewed for potential irregularities or improper coordination among counterparties or media coverage.
“On the surface — and from the beginning — there appear to be patterns that warrant deeper review,” said one attorney familiar with the investigation. “The trustee’s appointment would make it possible to test those facts in court.”
“The chapter is literally not over,” added a restructuring advisor. “A trustee could bring accountability and a real shot at restitution.”
_____
The Tuscany twist: where it all went wrong
At the center of LuxUrban’s collapse lies the Tuscany lease — a master agreement allegedly sold to LuxUrban by Tuscany Legacy Leasing, an entity linked to St. Giles Hotels.
Court filings suggest Tuscany granted a long-term lease it had no authority to convey, then later used that same lease to justify a Confession of Judgment that froze millions in LuxUrban accounts.
That single maneuver — executed through a loophole in New York’s civil procedure — is widely viewed as the moment the company’s liquidity evaporated.
“The trustee will almost certainly go after that lease,” said a restructuring expert following the case. “If it’s proven fraudulent, it could unlock a large share of the company’s lost value.”
_____
A company that paid everyone — except itself
For workers, vendors, and guests, LuxUrban delivered. Payrolls were met, hotels stayed open, and employees made 115% of their contracted wages.
Behind the scenes, the company’s accounts bled dry under the weight of bureaucracy and unpaid obligations.
“This isn’t incompetence,” said a bankruptcy attorney involved in the case. “It’s what happens when a company performs too well in a system that rewards inefficiency.”
_____
A comeback on the horizon?
Despite the setbacks, optimism is returning.
Sources close to the process say LuxUrban could reopen two to three hotels in the coming weeks as part of a structured restart under new oversight.
If the trustee is appointed, recovery actions — from the unpaid City contracts to the disputed Tuscany lease — could turn LuxUrban’s narrative from collapse to comeback.
For now, its story stands as both a warning and a revelation: sometimes in New York, doing the right thing costs more than failing ever could.
Media Contact:
NyArtisinal.com
2025-10-11 02:086mo ago
2025-10-10 21:136mo ago
Benson Investment Management Loads Up With 22K IBM Shares Worth $6.4 Million
Benson Investment Management Company, Inc. disclosed a new position in International Business Machines (IBM -3.61%) on October 10, 2025, acquiring shares valued at approximately $6.38 million, as reported in its Form 13F filing for the quarter ended September 30, 2025.
What happenedBenson Investment Management Company, Inc. initiated a new equity stake in International Business Machines (IBM -3.61%), according to a filing with the Securities and Exchange Commission dated October 10, 2025. The fund bought approximately 22,622 shares, with an estimated transaction value of $6.38 million based on average prices for the third quarter of 2025. This marks International Business Machines' entry as a reportable holding for the fund.
What else to knowThe new International Business Machines position represents 2.18% of the firm's 13F assets under management as of September 30, 2025
Top holdings after the filing:
GLD: $14.68 million (5.0% of AUM) as of September 30, 2025GOOGL: $14.08 million (4.8% of AUM) as of September 30, 2025MSFT: $12.81 million (4.4% of AUM) as of September 30, 2025NVDA: $11.39 million (3.9% of AUM) as of September 30, 2025AMZN: $9.39 million (3.2% of AUM) as of September 30, 2025As of October 9, 2025, shares were priced at $288.23, up 23.02% over the past year and outperforming the S&P 500 by 12.53 percentage points
Company overviewMetricValueRevenue (TTM)$64.04 billionNet income (TTM)$5.83 billionDividend yield2.37%Price (as of market close October 9, 2025)$288.23Company snapshotProvides integrated solutions spanning software, consulting, infrastructure, and financing, including hybrid cloud platforms and enterprise software.
Generates revenue through licensing, subscription, consulting fees, infrastructure sales, and financing arrangements, leveraging a diversified technology and services portfolio.
Serves large enterprises and institutional clients in sectors such as banking, airlines, retail, and regulated industries worldwide.
International Business Machines is a global technology leader with a broad portfolio spanning software, consulting, infrastructure, and financing solutions. The company focuses on hybrid cloud, artificial intelligence, and mission-critical IT services to support enterprise digital transformation.
Foolish takeBenson Investment Management Company took the plunge and invested in a new position in IBM during Q3 2025 that was worth over $6 million, representing about 2% of its total portfolio. This puts IBM in Benson’s top 15 holdings, with a larger percentage share than even Apple and Dell.
This could be a bullish signal from Benson about IBM, but it’s also objectively been a strong stock this year, putting up 20% gains year-to-date. The business is solid, with many new partnerships in the works with a variety of industries. Perhaps its strongest position, however, is in the AI space, where IBM has positioned itself as a leader in enterprise AI solutions.
Unlike general purpose generative AI, or public facing LLMs, many of IBM’s AI solutions are targeted to specific clients or industries, especially those that are highly regulated. This helps the company keep a lid on costs, and has generated a considerable backlog for the product, ensuring interest for some time to come.
Benson’s opening a position in IBM during Q3 could represent a strong conviction in the stock, but may also have been an opportunistic move, considering IBM experienced a major drop in share price during the quarter, which it has since recovered from.
GlossaryForm 13F: A quarterly report filed by institutional investment managers disclosing their equity holdings to the Securities and Exchange Commission.
Assets under management (AUM): The total market value of investments managed on behalf of clients by a fund or firm.
Reportable holding: A security position that meets the minimum threshold for mandatory disclosure in regulatory filings.
Hybrid cloud: An IT architecture combining private and public cloud services for greater flexibility and efficiency.
Dividend yield: Annual dividends per share divided by the share price, expressed as a percentage.
Outperforming: Achieving a higher return than a specified benchmark or index over a given period.
Quarter ended: The last day of a three-month financial reporting period.
TTM: The 12-month period ending with the most recent quarterly report.
Institutional clients: Large organizations, such as banks or pension funds, that invest substantial sums in financial markets.
Stake: The ownership interest or amount of shares held in a company.
Filing: An official document submitted to a regulatory authority, such as the Securities and Exchange Commission, to disclose financial or ownership information.
Kristi Waterworth has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Amazon, Apple, International Business Machines, Microsoft, and Nvidia. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
2025-10-11 02:086mo ago
2025-10-10 21:166mo ago
Shattuck Labs, Inc. (STTK) Presents at The United European Gastroenterology (UEG) Congress UEG Week 2025 Transcript
Shattuck Labs, Inc. (NASDAQ:STTK) The United European Gastroenterology (UEG) Congress UEG Week 2025 October 8, 2025 10:00 AM EDT
Company Participants
Taylor Schreiber - Co-Founder, CEO & Director
Conference Call Participants
Yu Fan - Wedbush Securities Inc., Research Division
Marla C Dubinsky
David De Vries - TR1X, Inc.
David Nierengarten - Wedbush Securities Inc., Research Division
Conversation
Yu Fan
Wedbush Securities Inc., Research Division
Okay. Good morning, everybody. Thank you for joining us today. This is Wednesday, October 8. This is the first of what we hope to be many installments in the Wedbush Rewind series in which we review key highlights from conferences in our sector. The first installment will focus on the UEGW conference in Berlin. This was a very exciting conference with many updates in the IBD space.
Joining me today is David Nierengarten, Managing Director of the Healthcare Equity Research team at Wedbush, along with Dr. Marla Dubinsky, Director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at Mount Sinai. We are also joined by David De Vries M. Phil, CEO of Tr1X Bio; as well as Taylor Schreiber, MD, PhD and CEO of Shattuck Labs.
For the audience, we encourage you to participate in our discussion with Q&A. There is a chat feature in the bottom of your window. Please ask questions to us and we will try to address them during the session and also a Q&A session at the end.
With that, I'll turn it over to our -- I will begin speaking with Dr. Marla Dubinsky, of Mount Sinai. Marla, thank you so much for joining us today. We really appreciate it.
Marla C Dubinsky
No problem. Your timing cannot be better. I just landed from UEGW. So I'll be able to give you live right away what the impressions are in the
Recommended For You
2025-10-11 02:086mo ago
2025-10-10 21:236mo ago
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lantheus To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Lantheus between February 26, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) and reminds investors of the November 10, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
According to the complaint, defendants provided investors with misleading statements concerning the true state of Pylarify's competitive position; notably, that Lantheus was not equipped to properly assess the pricing and competitive dynamics for Pylarify, risking Pylarify's price point, revenue, and overall growth potential. These statements caused Plaintiff and other shareholders to purchase Lantheus' securities at artificially inflated prices.
Investors began to question the veracity of Defendants' public statements on May 7, 2025, when Lantheus reported its first quarter results below market expectations with Pylarify's performance particularly falling short. Then, on August 6, 2025, Lantheus again announced disappointing results and significantly reduced growth expectations for Pylarify, which had fallen 8.3% year-over-year, and slashed fiscal year 2025 growth projections. Defendants attributed the losses to the ongoing competition, impacting Pylarify's pricing dynamics.
Investors and analysts reacted promptly to Lantheus' revelations. The price of Lantheus' common stock declined dramatically. From a closing market price of $72.83 per share on August 5, 2025, Lantheus' stock price fell to $51.87 per share on August 6, 2025, a decline of about 28.8% in the span of one day.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Lantheus' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Lantheus Holdings, Inc. class action, go to www.faruqilaw.com/LNTH or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
SOURCE Faruqi & Faruqi, LLP
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
2025-10-11 02:086mo ago
2025-10-10 21:496mo ago
C3.Ai Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against C3.ai, Inc. - AI
, /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have untilOctober 21, 2025 to file lead plaintiff applications in a securities class action lawsuit against C3.ai, Inc. ("C3" or the "Company") (NYSE: AI), if they purchased the Company's securities between February 26, 2025 to August 8, 2025, inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District of California.
What You May Do
If you purchased securities of C3 and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-ai/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by October 21, 2025.
About the Lawsuit
C3 and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On August 8, 2025, the Company disclosed disappointing preliminary financial results for 1Q 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing its poor sales results and lowered guidance to "the reorganization with new leadership" as well as the health ailments of its Chief Executive Officer.
On this news, the price of C3's shares fell from a closing price of $22.13 per share on August 8, 2025 to $16.47 per share on August 11, 2025, a decline of about 25.58%.
The case is John Liggett Sr. v. C3.ai, Inc., et al., No. 25-cv-07129.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
2025-10-11 02:086mo ago
2025-10-10 21:506mo ago
Dow Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dow Inc. - DOW
, /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have untilOctober 28, 2025 to file lead plaintiff applications in a securities class action lawsuit against Dow Inc. (NYSE: DOW), if they purchased the Company's securities between January 30, 2025 and July 23, 2025, inclusive (the "Class Period"). This action is pending in the United States District Court for the Eastern District of Michigan.
What You May Do
If you purchased securities of Dow and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-dow/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by October 28, 2025.
About the Lawsuit
Dow and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On July 24, 2025, the Company disclosed a 2Q 2025 non-GAAP loss per share of $0.42, much larger than the approximate $0.17 to $0.18 per share loss expected by analysts, and net sales of $10.1 billion, representing a 7.3% year-over-year decline and missing consensus estimates by $130 million, "reflecting declines in all operating segments" due in part to "the lower-for-longer earnings environment that our industry is facing, amplified by recent trade and tariff uncertainties." Further, the Company disclosed that it was cutting its dividend in half, from $0.70 per share to only $0.35 per share, citing the need for "financial flexibility amidst a persistently challenging macroeconomic environment."
On this news, the price of Dow's shares fell $5.30 per share, or 17.45%, to close at $25.07 per share on July 24, 2025.
The case is Sarti v. Dow Inc., No. 25-cv-12744.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
2025-10-11 02:086mo ago
2025-10-10 21:516mo ago
V.F. Corporation Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against V.F. Corporation - VFC
, /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have untilNovember 12, 2025 to file lead plaintiff applications in a securities class action lawsuit against V.F. Corporation. (NYSE: VFC), if they purchased or otherwise acquired VFC securities between October 30, 2023 and May 20, 2025, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Colorado.
What You May Do
If you purchased securities of V.F. and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-vfc/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by November 12, 2025.
About the Lawsuit
V.F. and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On May 21, 2025, the Company announced its fourth quarter and full-year fiscal 2025 results, disclosing a significant decline in its Vans brand growth trajectory, which decreased from an 8% loss the quarter before to a 20% loss in the fourth quarter, and noting such decline would continue through the next quarter, largely due to "a direct effect of deliberately reduced revenue to eliminate unprofitable or unproductive businesses" and "an additional set of deliberate actions" already in place but previously unannounced.
On this news, the price of V.F.'s shares fell from a closing price of $14.43 per share on May 20, 2025 to $12.15 per share on May 21, 2025, a decline of about 15.8% in the span of just a single day.
The case is Brenton v. V.F. Corporation, No. 25-cv-02878.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
2025-10-11 02:086mo ago
2025-10-10 21:526mo ago
Fluor Corporation Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Fluor Corporation - FLR
, /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have untilNovember 14, 2025 to file lead plaintiff applications in a securities class action lawsuit against Fluor Corporation (NYSE: FLR), if they purchased or otherwise acquired the Company's securities between February 18, 2025 and July 31, 2025, inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District of Texas.
What You May Do
If you purchased securities of Fluor and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-flr/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by November 14, 2025.
About the Lawsuit
Fluor and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On August 1, 2025, the Company announced its financial results for the second quarter of 2025, disclosing a Q2 non-GAAP EPS of $0.43, missing consensus estimates by $0.13, and revenue of $3.98 billion, representing a 5.9% year-over-year decline and missing consensus estimates by $570 million due to growing costs in multiple infrastructure projects due to subcontractor design errors, price increases, and scheduling delays, as well as reduced capital spending by customers. The Company also disclosed a negatively revised financial outlook for FY 2025, guiding to adjusted EBITDA of $475 million to $525 million, down significantly from Defendants' prior guidance of $575 million to $675 million, and adjusted EPS of $1.95 per share to $2.15 per share, down significantly from Defendants' prior guidance of $2.25 per share to $2.75 per share.
On this news, the price of Fluor's shares fell $15.35 per share, or 27.04%, to close at $41.42 per share on August 1, 2025.
The case is Maglione v. Fluor Corporation, et al., No. 25-cv-02496.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
2025-10-11 02:086mo ago
2025-10-10 21:536mo ago
KBR Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against KBR, Inc. - KBR
, /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have untilNovember 18, 2025 to file lead plaintiff applications in a securities class action lawsuit against KBR, Inc. (NYSE: KBR), if they purchased or otherwise acquired the Company's securities between May 6, 2025 and June 19, 2025, inclusive (the "Class Period"). This action is pending in the United States District Court for the Southern District of Texas.
What You May Do
If you purchased securities of KBR and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-kbr/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by November 18, 2025.
About the Lawsuit
KBR and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On June 19, 2025, HomeSafe Alliance ("HomeSafe"), a KBR joint venture in which KBR has a 72% economic interest, disclosed that it received "a notice from the U.S. Department of Defense's Transportation Command (TRANSCOM) terminating the Global Household Goods Contract, which HomeSafe won in 2021 to transform the military move system for the benefit of service members and their families."
On this news, the price of KBR's shares fell $3.85 per share, or 7.29%, to close at $48.93 on June 20, 2025. On June 23, 2025, the next trading day, KBR stock fell a further $1.30, or 2.65%, to close at $47.63 on June 23, 2025.
The case is Norrman v. KBR, Inc., et al., No. 25-cv-04464.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
Ripple (XRP) is expanding its global reach once again, this time entering the Kingdom of Bahrain through a new partnership with Bahrain Fintech Bay (BFB). At the same time, new data shows that corporate XRP treasuries have climbed above $11.5 billion following a fresh purchase from Reliance Global.
2025-10-11 01:076mo ago
2025-10-10 19:006mo ago
Bitcoin Looks Far From Overbought as “Stars Align” for ETF Surge
Bitcoin (BTC) continues to show strength above $122,000, with analysts suggesting that the market remains far from overheated despite recent highs. As institutional demand intensifies and exchange-traded fund (ETF) inflows accelerate, experts say the top cryptocurrency could be entering a powerful phase of sustained growth in the final quarter of 2025.
2025-10-11 01:076mo ago
2025-10-10 19:096mo ago
Bitcoin Crashes Hard After Trump's 100% Tariff on China Announcement
Bitcoin Suffers Its Worst Crash of the YearThe crypto market was thrown into chaos late Friday as Bitcoin ($BTC) crashed from above $120,000 to a low near $111,000, wiping out billions in market value within hours. The sudden drop marks the steepest one-day decline of 2025, with BTC falling over 7% in 24 hours and triggering a wider sell-off across all major altcoins.
The catalyst? It's President Trump.
This shock announcement rattled global markets, sending investors fleeing from risk assets — including crypto — in a classic risk-off move.
Chart Analysis: Freefall from Key SupportAs shown in the below chart, BTCUSD collapsed below multiple key levels in a single candle:
Lost support at $118,600, turning it into resistance.Fell through the 50-day SMA (~$114,500), signaling a sharp momentum shift.Briefly touched $111,350, just above a crucial support cluster near $110,000 — the last defense before the 200-day SMA (~$106,600).
BTC/USD 1-day chart - TradingView
The daily candle formed a massive red engulfing bar, confirming heavy selling pressure and panic liquidation across exchanges. This structure resembles previous macro breakdowns, though the speed and scale of this one make it stand out as the worst single-day Bitcoin correction in 2025 so far.
If the $111K–$110K zone breaks, the next downside targets lie near $106K (200-day SMA) and psychological $100K support.
Total Market: Over $400 Billion Wiped OutThe broader crypto market mirrored Bitcoin’s collapse. According to total market cap data (attached chart), the crypto market fell over 10%, plunging from around $4.1 trillion to just above $3.6 trillion before a slight rebound attempt.
Every major sector — from DeFi to Layer 2s to AI tokens — was hit hard.Ethereum (ETH) dropped back below $4,000.BNB, SOL, and XRP all saw double-digit declines.Even top performers of early Uptober like ZEC and TAO gave up a large part of their weekly gains.
Total crypto market cap in the past hours - TradingView
The sudden liquidity crunch caused several leveraged traders to be liquidated as funding rates flipped negative, adding more downward momentum.
Why the Tariff News Hit So HardTrump’s 100% China tariff policy, effective November 1st, reignites fears of a global trade war, threatening supply chains, inflation control, and economic stability — the exact macro conditions that often spook crypto investors.
While Bitcoin has often been viewed as a hedge against geopolitical chaos, this time the move suggests traders are prioritizing cash and stability over risk exposure. The immediate reaction across futures and spot markets shows that institutions are reducing exposure until macro clarity returns. It is also worth noting that all markets crashed, not only cryptos.
What’s Next for Bitcoin?Analysts see two possible short-term paths:
1. Quick Recovery (V-shape bounce)If Bitcoin holds above $111K–$110K and buying volume returns, a retest of $118K–$120K could happen in the coming days. That would confirm this as a panic dip rather than a full reversal.
2. Extended CorrectionIf panic persists and macro pressure builds, BTC could drop toward $106K–$100K, testing long-term moving averages before stabilizing.
Given that Uptober historically brings bullish trends, traders are watching whether this tariff-driven crash becomes a short-term buying opportunity or the start of a broader risk-off phase.